Table of Contents Author Guidelines Submit a Manuscript
International Journal of Alzheimer’s Disease
Volume 2012, Article ID 489428, 9 pages
http://dx.doi.org/10.1155/2012/489428
Review Article

Apolipoprotein E: Essential Catalyst of the Alzheimer Amyloid Cascade

1Department of Molecular Medicine, Suncoast Gerontology Center, Johnnie B. Byrd Sr. Alzheimer’s Institute, University of South Florida, Tampa, FL 33620, USA
2Department of Neurology and Linda Crnic Institute for Downs Syndrome, School of Medicine, University of Colorado Aurora, CO 80045, USA
3Departments of Neurology, Pathology, and Psychiatry, New York University School of Medicine, New York, NY 10016, USA

Received 16 December 2011; Accepted 23 April 2012

Academic Editor: Laura Morelli

Copyright © 2012 Huntington Potter and Thomas Wisniewski. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [35 citations]

The following is the list of published articles that have cited the current article.

  • Antoneta Granic, and Huntington Potter, “Mitotic Spindle Defects and Chromosome Mis-Segregation Induced by LDL/Cholesterol-Implications for Niemann-Pick C1, Alzheimer's Disease, and Atherosclerosis,” Plos One, vol. 8, no. 4, 2013. View at Publisher · View at Google Scholar
  • Jency Thomas, Manohar Lal Garg, and Douglas William Smith, “Dietary supplementation with resveratrol and/or docosahexaenoic acid alters hippocampal gene expression in adult C57Bl/6 mice,” Journal of Nutritional Biochemistry, vol. 24, no. 10, pp. 1735–1740, 2013. View at Publisher · View at Google Scholar
  • Christina Rose Kyrtsos, and John S. Baras, “STUDYING THE ROLE OF ApoE IN ALZHEIMER'S DISEASE PATHOGENESIS USING A SYSTEMS BIOLOGY MODEL,” Journal of Bioinformatics and Computational Biology, vol. 11, no. 5, 2013. View at Publisher · View at Google Scholar
  • Jency Thomas, Manohar Lal Garg, and Douglas William Smith, “Dietary supplementation with resveratrol and/or docosahexaenoic acid alters hippocampal gene expression in adult C57Bl/6 mice,” Journal of Nutritional Biochemistry, vol. 24, no. 10, pp. 1735–1740, 2013. View at Publisher · View at Google Scholar
  • Allal Boutajangout, and Thomas Wisniewski, “The Innate Immune System in Alzheimer’s Disease,” International Journal of Cell Biology, vol. 2013, pp. 1–7, 2013. View at Publisher · View at Google Scholar
  • Mengyuan Liu, Ya Ruth Huo, Shuling Liu, Zhihong Shi, Shuai Liu, Thomas Wisniewski, Jinhuan Wang, and Yong Ji, “Apolipoprotein Ε e4 Frequency Is Increased among Chinese Patients with Frontotemporal Dementia and Alzheimer's Disease,” Dementia and Geriatric Cognitive Disorders, vol. 36, no. 3-4, pp. 163–170, 2013. View at Publisher · View at Google Scholar
  • Csilla Ari, Sergiy I. Borysov, Jiashin Wu, Jaya Padmanabhan, and Huntington Potter, “Alzheimer amyloid beta inhibition of Eg5/kinesin 5 reduces neurotrophin and/or transmitter receptor function,” Neurobiology of Aging, vol. 35, no. 8, pp. 1839–1849, 2014. View at Publisher · View at Google Scholar
  • Sandra D. Mulder, Henrietta M. Nielsen, Marinus A. Blankenstein, Piet Eikelenboom, and Robert Veerhuis, “Apolipoproteins E and J interfere with amyloid-beta uptake by primary human astrocytes and microglia in vitro,” Glia, vol. 62, no. 4, pp. 493–503, 2014. View at Publisher · View at Google Scholar
  • Fernando Goni, “Immunotherapy for Alzheimer's disease,” Biochemical Pharmacology, vol. 88, no. 4, pp. 499–507, 2014. View at Publisher · View at Google Scholar
  • Priyanka Sabharwal, and Thomas Wisniewski, “Novel immunological approaches for the treatment of Alzheimer's disease,” Chinese Journal of Contemporary Neurology and Neurosurgery, vol. 14, no. 3, pp. 139–151, 2014. View at Publisher · View at Google Scholar
  • Shan Liu, Ariel Breitbart, Yanjie Sun, Pankaj D. Mehta, Allal Boutajangout, Henrieta Scholtzova, and Thomas Wisniewski, “Blocking the apolipoprotein E/Amyloid beta interaction in triple transgenic mice ameliorates Alzheimer's disease related amyloid beta and tau pathology,” Journal of Neurochemistry, vol. 128, no. 4, pp. 577–591, 2014. View at Publisher · View at Google Scholar
  • Dean Hartley, Thomas Blumenthal, Maria Carrillo, Gilbert DiPaolo, Lucille Esralew, Katheleen Gardiner, Ann-Charlotte Granholm, Khalid Iqbal, Michael Krams, Cynthia Lemere, Ira Lott, William Mobley, Seth Ness, Ralph Nixon, Huntington Potter, Roger Reeves, Marwan Sabbagh, Wayne Silverman, Benjamin Tycko, Michelle Whitten, and Thomas Wisniewski, “Down syndrome and Alzheimer's disease: Common pathways, common goals,” Alzheimer's & Dementia, 2014. View at Publisher · View at Google Scholar
  • Arash Nazeri, Habib Ganjgahi, Tina Roostaei, Thomas Nichols, and Mojtaba Zarei, “Imaging proteomics for diagnosis, monitoring and prediction of Alzheimer's disease,” Neuroimage, vol. 102, pp. 657–665, 2014. View at Publisher · View at Google Scholar
  • Calvin C. Willhite, Nataliya A. Karyakina, Robert A. Yokel, Nagarajkumar Yenugadhati, Thomas M. Wisniewski, Ian M.F. Arnold, Franco Momoli, and Daniel Krewski, “Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts,” Critical Reviews in Toxicology, vol. 44, no. S4, pp. 1–80, 2014. View at Publisher · View at Google Scholar
  • Li Zhu, Minghao Zhong, Gregory A. Elder, Mary Sano, David M. Holtzman, Sam Gandy, Christopher Cardozo, Vahram Haroutunian, Nikolaos K. Robakis, and Dongming Cai, “Phospholipid dysregulation contributes to ApoE4-associated cognitive deficits in Alzheimer's disease pathogenesis,” Proceedings Of The National Academy Of Sciences Of The United States Of America, vol. 112, no. 38, pp. 11965–11970, 2015. View at Publisher · View at Google Scholar
  • Jenna M. Tarasoff-Conway, Roxana O. Carare, Ricardo S. Osorio, Lidia Glodzik, Tracy Butler, Els Fieremans, Leon Axel, Henry Rusinek, Charles Nicholson, Berislav V. Zlokovic, Blas Frangione, Kaj Blennow, Joël Ménard, Henrik Zetterberg, Thomas Wisniewski, and Mony J. de Leon, “Clearance systems in the brain—implications for Alzheimer disease,” Nature Reviews Neurology, 2015. View at Publisher · View at Google Scholar
  • Thomas Wisniewski, and Fernando Goñi, “Immunotherapeutic Approaches for Alzheimer’s Disease,” Neuron, vol. 85, no. 6, pp. 1162–1176, 2015. View at Publisher · View at Google Scholar
  • Angela L. Jefferson, Alexa S. Beiser, Sudha Seshadri, Philip A. Wolf, and Rhoda Au, “APOE and mild cognitive impairment: the Framingham Heart Study,” Age And Ageing, vol. 44, no. 2, pp. 307–311, 2015. View at Publisher · View at Google Scholar
  • Thomas Wisniewski, and Eleanor Drummond, “Developing therapeutic vaccines against Alzheimer’s disease,” Expert Review of Vaccines, pp. 1–15, 2015. View at Publisher · View at Google Scholar
  • Margaret Esiri, Steven Chance, Catharine Joachim, Donald Warden, Aidan Smallwood, Carolyn Sloan, Sharon Christie, Gordon Wilcock, and A. David Smith, “Cerebral Amyloid Angiopathy, Subcortical White Matter Disease and Dementia: Literature Review and Study in OPTIMA,” Brain Pathology, vol. 25, no. 1, pp. 51–62, 2015. View at Publisher · View at Google Scholar
  • T. L. Cerajewska, M. Davies, and N. X. West, “Periodontitis: a potential risk factor for Alzheimer's disease,” British Dental Journal, vol. 218, no. 1, 2015. View at Publisher · View at Google Scholar
  • Richard A. Hickman, Arline Faustin, and Thomas Wisniewski, “Alzheimer Disease and Its Growing Epidemic,” Neurologic Clinics, 2016. View at Publisher · View at Google Scholar
  • Karine Bourgade, Gilles Dupuis, Eric H. Frost, and Tamàs Fülöp, “Anti-Viral Properties of Amyloid-β Peptides,” Journal of Alzheimer's Disease, pp. 1–20, 2016. View at Publisher · View at Google Scholar
  • Huntington Potter, “New genetic links between Alzheimer disease and immune-mediated diseases revealed by overlapping genome-wide association study hits,” JAMA Neurology, vol. 73, no. 6, pp. 638–640, 2016. View at Publisher · View at Google Scholar
  • Fabio Di Domenico, Gilda Pupo, Esther Giraldo, Mari-Carmen Badia, Paloma Monllor, Ana Lloret, Maria Eugenia Schinina, Alessandra Giorgi, Chiara Cini, Antonella Tramutola, D. Allan Butterfield, Jose Vina, and Marzia Perluigi, “Oxidative signature of cerebrospinal fluid from mild cognitive impairment and Alzheimer disease patients,” Free Radical Biology And Medicine, vol. 91, pp. 1–9, 2016. View at Publisher · View at Google Scholar
  • Mi Zhou, and Mao-Sheng Yang, “Relationship between intestinal flora microenvironment and colorectal cancer,” World Chinese Journal of Digestology, vol. 24, no. 36, pp. 4759–4765, 2016. View at Publisher · View at Google Scholar
  • Lary C. Walker, “Proteopathic Strains and the Heterogeneity of Neurodegenerative Diseases,” Annual Review of Genetics, vol. 50, pp. 329–346, 2016. View at Publisher · View at Google Scholar
  • Shan Liu, Shinae Park, Grant Allington, Frances Prelli, Yanjie Sun, Mitchell Martá-Ariza, Henrieta Scholtzova, Goutam Biswas, Bernard Brown, Philip B. Verghese, Pankaj D. Mehta, Yong-Uk Kwon, and Thomas Wisniewski, “Targeting Apolipoprotein E/Amyloid β Binding by Peptoid CPO_Aβ17-21 P Ameliorates Alzheimer’s Disease Related Pathology and Cognitive Decline,” Scientific Reports, vol. 7, no. 1, 2017. View at Publisher · View at Google Scholar
  • Eleanor Drummond, Xiaoxia Han, Yongzhao Shao, Jiri G. Safar, Beatrix Ueberheide, Thomas Wisniewski, Shruti Nayak, Arline Faustin, Geoffrey Pires, Richard A. Hickman, Manor Askenazi, Mark Cohen, Tracy Haldiman, and Chae Kim, “Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer’s disease,” Acta Neuropathologica, vol. 133, no. 6, pp. 933–954, 2017. View at Publisher · View at Google Scholar
  • Shanna L. Burke, Peter Maramaldi, Tamara Cadet, and Walter Kukull, “Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E,” International Journal of Geriatric Psychiatry, 2017. View at Publisher · View at Google Scholar
  • Gilles Dupuis, Eric H. Frost, Karine Bourgade, and Tamàs Fülöppp. 221–240, 2017. View at Publisher · View at Google Scholar
  • Eleanor Drummond, and Thomas Wisniewski, “Alzheimer’s disease: experimental models and reality,” Acta Neuropathologica, vol. 133, no. 2, pp. 155–175, 2017. View at Publisher · View at Google Scholar
  • Karine Bourgade, Tamàs Fülöp, Gilles Dupuis, and Eric H. Frost, “Anti-Viral Properties of Amyloid-β Peptides,” Advances in Alzheimer's Disease, vol. 5, pp. 221–240, 2017. View at Publisher · View at Google Scholar
  • Neha Sinha, Chelsie N. Berg, Nicholas J. Tustison, Ashlee Shaw, Diane Hill, Michael A. Yassa, and Mark A. Gluck, “APOE ε4 Status in Healthy Older African Americans is Associated with Deficits in Pattern Separation and Hippocampal Hyperactivation,” Neurobiology of Aging, 2018. View at Publisher · View at Google Scholar
  • Veronica Tisato, Giovanni Zuliani, Marco Vigliano, Giovanna Longo, Eugenia Franchini, Paola Secchiero, Giorgio Zauli, Elvezia Maria Paraboschi, Ajay Vikram Singh, Maria Luisa Serino, Beatrice Ortolani, Amedeo Zurlo, Cristina Bosi, Antonio Greco, Davide Seripa, Rosanna Asselta, and Donato Gemmati, “Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in cognitive impairment diseases,” Plos One, vol. 13, no. 3, pp. e0193867, 2018. View at Publisher · View at Google Scholar